FluoroPharma Medical Inc (FPMI):企業の財務・戦略的SWOT分析

◆英語タイトル:FluoroPharma Medical Inc (FPMI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH66772FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
FluoroPharma Medical Inc (FluoroPharma) is a molecular imaging company that develops and commercialize proprietary medical diagnostic imaging products. The company develops breakthrough positron emission tomography imaging agents for the assessment and detection of acute and chronic forms of coronary artery disease. Its positron emission tomography imaging agents include VasoPET, cardioPET, BFPET, and AZPET. FluoroPharma provides agents for detection of amyloid plaque in Alzheimer’s disease, inflamed atherosclerotic plaque in peripheral arteries, and agents for detection of certain types of cancer. The company’s technology consists of molecular positron emission tomography agents for the cardiovascular, oncology and neurology arenas. Its products are used in molecular imaging market, cardiovascular market and additional diagnostic markets. FluoroPharma is headquartered in Montclair, New Jersey, the US.

This comprehensive SWOT profile of FluoroPharma Medical Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of FluoroPharma Medical Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

FluoroPharma Medical Inc – Key Information
FluoroPharma Medical Inc – Overview
FluoroPharma Medical Inc – Key Employees
FluoroPharma Medical Inc – Key Employee Biographies
FluoroPharma Medical Inc – Key Operational Heads
FluoroPharma Medical Inc – Major Products and Services
FluoroPharma Medical Inc – History
FluoroPharma Medical Inc – Company Statement
FluoroPharma Medical Inc – Locations And Subsidiaries
FluoroPharma Medical Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

FluoroPharma Medical Inc – Business Description
FluoroPharma Medical Inc – Corporate Strategy
FluoroPharma Medical Inc – SWOT Analysis
SWOT Analysis – Overview
FluoroPharma Medical Inc – Strengths
FluoroPharma Medical Inc – Weaknesses
FluoroPharma Medical Inc – Opportunities
FluoroPharma Medical Inc – Threats
FluoroPharma Medical Inc – Key Competitors

Section 3 – Company Financial Performance Charts

FluoroPharma Medical Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

FluoroPharma Medical Inc, Key Information
FluoroPharma Medical Inc, Key Ratios
FluoroPharma Medical Inc, Share Data
FluoroPharma Medical Inc, Major Products and Services
FluoroPharma Medical Inc, History
FluoroPharma Medical Inc, Key Employees
FluoroPharma Medical Inc, Key Employee Biographies
FluoroPharma Medical Inc, Key Operational Heads
FluoroPharma Medical Inc, Other Locations
FluoroPharma Medical Inc, Subsidiaries
FluoroPharma Medical Inc, Key Competitors
FluoroPharma Medical Inc, SWOT Analysis
FluoroPharma Medical Inc, Ratios based on current share price
FluoroPharma Medical Inc, Annual Ratios
FluoroPharma Medical Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[FluoroPharma Medical Inc (FPMI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Reach Subsea ASA (REACH):企業の財務・戦略的SWOT分析
    Reach Subsea ASA (REACH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Infinite Group Inc (IMCI):企業の財務・戦略的SWOT分析
    Summary Infinite Group Inc (IGI) is a technology company that offers IT service and support solutions virtualization and cybersecurity. The company offers Nodeware, an automated network vulnerability management system that assesses vulnerabilities in a computer network using scanning technology. Its …
  • 3D Systems Corporation:企業のM&A・事業提携・投資動向
    3D Systems Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 3D Systems Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Fujitsu Limited (6702):企業の財務・戦略的SWOT分析
    Fujitsu Limited (6702) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Starpharma Holdings Ltd (SPL):製薬・医療:M&Aディール及び事業提携情報
    Summary Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company’s developmen …
  • Rigaku Corporation:企業の戦略・SWOT・財務情報
    Rigaku Corporation - Strategy, SWOT and Corporate Finance Report Summary Rigaku Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Brigham and Women’s Hospital:企業のM&A・事業提携・投資動向
    Brigham and Women's Hospital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brigham and Women's Hospital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Motor Oil (Hellas) Corinth Refineries SA (MOH):企業の財務・戦略的SWOT分析
    Motor Oil (Hellas) Corinth Refineries SA (MOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Haworth, Inc.:企業の戦略・SWOT・財務分析
    Haworth, Inc. - Strategy, SWOT and Corporate Finance Report Summary Haworth, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Suzano SA (SUZB5):企業の財務・戦略的SWOT分析
    Suzano SA (SUZB5) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Women’s Choice Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Women's Choice Pharmaceuticals LLC (WCP) is a pharmaceutical company that offers prescription products for women’s health care and urology markets. The company’s products include fem pH, a therapeutic vaginal jelly that is used to promote and maintain vaginal acidity caused by diabetes, horm …
  • United Breweries Limited:企業の戦略・SWOT・財務情報
    United Breweries Limited - Strategy, SWOT and Corporate Finance Report Summary United Breweries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Louisiana-Pacific Corporation:戦略・SWOT・企業財務分析
    Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report Summary Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Schneider Electric (Australia) Pty Ltd:企業の戦略的SWOT分析
    Schneider Electric (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Autobio Diagnostics Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Autobio Diagnostics Co Ltd (Autobio) is a clinical diagnostic company that provides research and development; production and distribution of clinical diagnostic products. The company provides products such as immunoassays, mycoplasma, blood culture bottle, bacterial vaginosis, microplate lum …
  • Ultragenyx Pharmaceutical Inc (RARE):製薬・医療:M&Aディール及び事業提携情報
    Summary Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops life-enhancing therapeutics for rare and ultra-rare genetic diseases. Its only marketed product, Mepsevii (vestronidase alfa) is the first indication approved for the treatment of adults and children with Muc …
  • MicroStrategy Inc (MSTR):企業の財務・戦略的SWOT分析
    MicroStrategy Inc (MSTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Craneware plc (CRW):企業の財務・戦略的SWOT分析
    Summary Craneware plc (Craneware) is a healthcare technology company that provides revenue integrity solutions. The company provides patient engagement, charge capture and pricing; coding integrity, and revenue recovery and retention products, chargemaster tool kit, online reference tool kit, physic …
  • Gartner Inc (IT):企業の財務・戦略的SWOT分析
    Gartner Inc (IT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Denka Co Ltd (4061):企業の財務・戦略的SWOT分析
    Denka Co Ltd (4061) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆